Low molecular weight heparin in management and prevention of portal vein thrombosis

Thrombosis Research

Volumn 134, Issue 4, 2014, Pages 761-762

  Lisman, Ton ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

EDITORIAL; HUMAN; LIVER CIRRHOSIS; PARTIAL HEPATECTOMY; PORTAL VEIN THROMBOSIS; THROMBOSIS PREVENTION; COMPLICATION; DRUG EFFECTS; PATHOLOGY; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIVER CIRRHOSIS; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS;

EID: 84908119309     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.08.003     Document Type: Editorial

References (20)

1. Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther Feb 1 2010;31(3):366-74.
2. Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology Apr 2008;47(4):1384-93.
3. Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56(Suppl. 1):S25-38.
4. Lisman T, Kamphuisen PW, Northup PG, Porte RJ. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. J Hepatol 2013 Aug;59(2):358-66.
5. Intagliata N, Maitland H, Northup P, Caldwell S. Treating thrombosis in cirrhosis patients with new oral agents: Ready or not? Hepatology May 15 2014. http://dx.doi.org/10.1002/hep.27225 (in press).
6. Martinez M, Tandra A, Vuppalanchi R. Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology 2014;60(1):425-6.
7. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood Aug 12 2010;116(6):878-85.
8. Intagliata NM, Henry ZH, Shah N, Lisman T, Caldwell SH, Northup PG. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int Jan 2014;34(1):26-32.
9. Gomez Cuervo C, Bisbal Pardo O, Perez-Jacoiste Asin MA. Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: a systematic review and meta-analysis. Thromb Res Oct 2013;132(4):414-9.
10. Villa E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients with Advanced Cirrhosis. Gastroenterology Jul 18 2012;143(5):1253-60.
11. Duffy JP, Hong JC, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, et al. Vascular complications of orthotopic liver transplantation: experience inmore than 4,200 patients. J Am Coll Surg May 2009;208(5):896-903 [discussion 903-5].
12. Yoshiya S, Shirabe K, Nakagawara H, Soejima Y, Yoshizumi T, Ikegami T, et al. Portal vein thrombosis after hepatectomy. World J Surg Jun 2014;38(6):1491-7.
13. Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg Feb 2005;241(2):208-16.
14. Yamashita Y, Bekki Y, Imai D, Ikegami T, Yoshizumi T, Ikeda T, et al. Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic reection in patients with liver cancer. Thromb Res 2014;134(4):826-31 [in this issue].
15. De Pietri L, Montalti R, Begliomini B, Scaglioni G, Marconi G, Reggiani A, et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol Jul 2010;27(7):608-16.
16. Louis SG, Barton JS, Riha GM, Orloff SL, Sheppard BC, Pommier RF, et al. The international normalized ratio overestimates coagulopathy in patients after major hepatectomy. Am J Surg May 2014;207(5):723-7 [discussion 727].
17. De Martino RR, Goodney PP, Spangler EL, Wallaert JB, Corriere MA, Rzucidlo EM, et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg Apr 2012;55(4):1035-1040.e4.
18. Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010 Mar;52(3):355-61.
19. Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, et al. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg Jun 2014;18(6):1116-24.
20. Reddy SK, Turley RS, Barbas AS, Steel JL, Tsung A, Marsh JW, et al. Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg Sep 2011;15(9):1602-10.